Last update 04 Nov 2024
Precision Molecular Inc.

Precision Molecular Inc.

Private Company|
Canada
|
www.precisionmol.com

Overview

Tags

Neoplasms
Other Diseases
Urogenital Diseases
Small molecule drug
Contrast agent
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Nervous System Diseases3
Endocrinology and Metabolic Disease2
Top 5 Drug TypeCount
Small molecule drug6
Contrast agent4
Synthetic peptide1
Top 5 TargetCount
PDL1(Programmed death-ligand 1)1
CAIX(Carbonic anhydrase IX)1
PSMA(Prostate-specific membrane antigen)1
FAP(Fibroblast activation protein alpha)1
TSPO(Translocator protein)1

Related

7
Drugs associated with Precision Molecular Inc.
PMI-01
Target
TSPO
Mechanism
TSPO inhibitors [+1]
Active Org.
Precision Molecular Inc.Precision Molecular Inc.
Originator Org.
Precision Molecular Inc.Precision Molecular Inc.
Active Indication
Neuritis
Inactive Indication
Inflammation
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
PMI-04
Target-
Mechanism
Magnetic resonance imaging enhancers [+1]
Active Org.
Precision Molecular Inc.Precision Molecular Inc. [+1]
Originator Org.
Precision Molecular Inc.Precision Molecular Inc.
Active Indication
Alzheimer Disease [+4]
Inactive Indication
Inflammation
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
PMI-05
Target
CAIX
Mechanism
CAIX inhibitors
Active Org.
D&D Pharmatech Co., Ltd.D&D Pharmatech Co., Ltd.Startup [+1]
Originator Org.
Precision Molecular Inc.Precision Molecular Inc.
Active Indication
Renal Cell Carcinoma [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Precision Molecular Inc.
NCT04749433 / TerminatedPhase 1IIT
A Phase 1 Study to Assess the Safety and Tolerability of PET Imaging With [11C]CPPC [5-cyano-N-(4-(4-[11C]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide] Radioligand in Patients With Amyotrophic Lateral Sclerosis
100 Clinical Results associated with Precision Molecular Inc.
Login to view more data
0 Patents (Medical) associated with Precision Molecular Inc.
Login to view more data
100 Deals associated with Precision Molecular Inc.
Login to view more data
100 Translational Medicine associated with Precision Molecular Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
Phase 1
4
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
PMI-05
 ( CAIX )		Renal Cell Carcinoma
More
Phase 1
PMI06-G
 ( PDL1 )		Neoplasms
More
Preclinical
PMI-21
 ( PSMA )		Metastatic Prostate Carcinoma
More
Preclinical
PMI-31
 ( FAP )		Neoplasms
More
Discovery
PMI-04
Inflammation
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free